Pat

rons
Emi
nentSpeaker
s Shr
iVal
labhbhai
M.Pat
el
Honor
abl
eChai
rman-Sar
vaVi
dyal
ayaKel
vani
Mandal

Dr
.Pr
iyankaPawar Honor
abl
ePr
esi
dent-Kadi
Sar
vaVi
shwav
idyal
aya
Associ
at
Amneal
eVicePr
Phar
esi
dent
maceuti
,
cal
s Pr
of.
Gar
giRaj
par
a
K.
B. I
nst
itut
eofPhar
maceuti
cal
Di
rect
or,
Kadi
Sar
vaVi
shwav
idyal
aya Educati
onandResear
ch
(
ACons
tit
uentCol
legeofKadi
Sar
vaVi
shwavi
dyal
aya)
Dr
.AnandHar
uger
i Dr
.Rohi
tSi
nghal
Di
rector
, Sr
.Saf
etyManager
,
Pharmacov
igi
l
ance,
IQVI
A I
QVIA Or
gani
zingCommi
ttee

Dr
.Anj
uDhi
man Mr
.SandeepDhi
man Pr
of.
S.S.
Deshpande
Associ
ateProfessor
, Associat
eDirect
or, Organizi
ngChai r
man
MaharshiDayanandUni
ver
sit
y &
SyneosHealt
h
Vi
cePr
esident,AcademicI
SPRA

Mr
.Gopal
Pat
el Mr
.Sat
eeshBabu Dr
.M.
N.Zaver
i
Vi
cePresi
dent
, Sr
.Manager
, Or
gani
zi
ngSecr
etar
y,I
SPRA
Ni
vagen SyneosHeal
th

Dr
.S.
P.Bhat
t
Mr
.Gur
iqbal
Singh Ms.
Shai
lySet
hi Or
gani
zi
ngSecr
etar
y,e-
FDP 2nd Nati
onalConvent i
onof
I
ndi anSocietyofPhar maceut
ical
Di
rect
or, Deput
yGeneralManager
,
RegWebConsul
ti
ngSer
vices Techi
nvent
ionLi
fecar
ePvtLtd
Dr
.V.
R.Mov
ali
ya
Or
gani
zi
ngJ
ointSecr
etar
y,I
SPRA
Regul ator
yAf f
air
s(ISPRA)&
Ms.
InduNambi
ar Ms.
Smi
taPat
el OneWeeke- Facult
yDevelopment
Progr am (
e-FDP)on
Local
Pati
entSaf
etyLead, F
ounderandDi
rect
orofQUI
CQGMP
Boehri
ngerI
ngel
hei
mI ndi
aPv
t.L
td.
Regi
str
ati
on
Coor
dinat
or
Dr
.Bhavi
taDhr
u;Dr
.AkashMat
hur
ia

Mr
.Ki
ranKol
he Mr
.Sumi
tJai
n
Onl
ineVenue
Vi
cePr
esi
dent
, Sr.
Manager
,
Coordi
nator
Dr
.Ni
ranj
anKanaki
;Dr
.Chi
ntanPat
el
Amneal
Phar
maceut
ical
s Uni
sonPhar
maceut
ical
sPvt
.Lt
d.

Fi
nance
Coordi
nat
or Dr
.Vi
nitMov
ali
ya;Dr
.KhushbooVaghel
a
Dr
.Mani
shMahaj
an Dr
.TusharN.
Meht
a
LeadMedicalaf
fai
rs, Vi
cePr
esi
dentAnalyt
ical
R&D, Soci
alMedia
Coordi
nat
or
Dr
.AkashMat
hur
ia
Cadil
aHealt
hCar e AmnealPhar
maceut i
cal
s

Dr
.
Gl
Ni
leshPandya
obalRegul
atoryLead,
Dr
.Tr
upt
iPat
hak
PharmaConsul
tant
GlobalRegul
atoryAairs
Regul
Astr
ator
yaf
aZeneca
fai
rsdir
ect
or, (
Dev
elopmentandQual
it
y&Regulat
oy)
Questk
,
ey i
nPhar maceutical
Dr
.Pr
adeepSi
ngh
I
ndust r
y:DueDi l
igence
Gl
obal
Regul
atoryAff
air
s,
I
ndust
ryAdvi
sor onCur r
entTrendsand
Practi
ces
Gr
oupmanager,
Pfiz
er
Dr
.Ashut
oshJ
ani
Head-COD,
VeedaCl
i
nical
Resear
ch

Panel
Discussi
on Mr
.Anki
tTr
ivedi
Dr
.Ni
ravChoksi SrTeam Lead,
SyneosHeal
thL
td Onl
i
ne
Shr
iV.
R.Shah Co-
Founder
,
Ex-
Deput
yCommi
ssi
oner
,FDCA I
sazi
Phar
ma&TechnoConsul
ti
ng 23-28J
an,2023
 F
acul
tyDev
elopmentPr
ogr
am (
FDP) WhoCanAt
tend?
AboutUs Regul
ati
ons pertai
ning to pharmaceuti
cal pr oduct
s are Academici
ans,
conti
nuousl
y changi
ng and cr
eating chal
lenges forglobal Pharmaceuti
calIndust
rial
Per
sonnel
,
phar
maceuticali
ndustr
y.Thi
saff
ect st
her egionalandglobal Cli
nical
Pract
iti
oners,
r
egul
ator
yr equi
rementsforproductapprov
al.Ther
efor
e,itis Resear
chSt
udent
s,
Kadi
Sar
vaVi
shwavi
dyal
aya i
mpor
tantforpharmaceut
ical
businessest
oimplementarobust
regul
ator
ystr
ategy
.Regul
ator
yissuesar
iseunexpectedl
yand
Kadi Sar v
a Vi shwav idyalaya ( KSV) i
s a Uni versi
ty cancreatesi
gni
fi
cantst
rai
nonacompany’ sr
esources.Agap Regi
str
ati
onDet
ail
s
est abl
ishedv ideGuj aratSt ateGov er
nmentAct21 ,2007in anal
ysi
sisar
egul
ator
yrev
iewpr
ocesst
hati
dent
if
iesdat
agaps
May 2007 .The uni v er
sity has been set up by Sarva i
nt he technicaldocumentati
on requi
red f
orprepari
ng the Ear
lyBi
rdRegi
str
ati
onF
ee
VidyalayaKel avaniMandal ;at rust wi
t h morethan 102 dossier & the appli
cati
on befor
e applyi
ng for r
egulator
y 300I
NR(
til
l16J
an2023)
year sofphilant hr
opic exist ence.Thetrustprovi
desneed approval
.Post-appr
oval
 
li
fecycl
emanagement  
i
sanint
egralpar
t
based educat ionbydev el
opi ngcoursesofcont emporary
Lat
eRegi
str
ati
onF
ee
ofmai nt
aini
ng the qual i
tyand saf etyofapr oduct.When i t
500I
NR(
all
regi
str
ati
onsaf
ter1
6Jan2023)
relevance.KSV i s a univer si
ty ofexcell
ence promoting comest or egulat
oryst r
ategies,CMC document at i
on pl
aya
research based act i
viti
es whi ch wouldf oster higher cruci
alroleindev elopingef f
icientregulatoryappr oachesfor Regi
str
ati
onLi
nk&QR:
economi cgrowt h. pharmaceutical
saswel lasbiologicalproducts.Anidealfacult
y
ht
tps:
/
/for
ms.
gle/
Tvxu79auXEr
5mLxBA
devel
opmentpr ogram i nt he areas ofpr ofessi
onalabili
ti
es
K.
B.I
nst
itut
eofPhar
maceut
ical
Educat
ion Useabov
eli
nkt
oRegi
ster
shouldprovi
deav ari
et yofoppor tunit
iesforthedev elopmentof
&Resear
ch speci
fic abi
li
ti
es in allfacult
y member s based on industr
ial
Visi
on:Thei nsti
tuteint
endst obethepr omi
nentpubl
ic needs,
desi
res,
andexpect
ati
onsf
orcur
rentandf
utur
erol
es. Or
researchandt eachi
nginstit
uteint
hef i
eldofphar
macy,
l
inkingthepeopleofGujarattot
henati
onandtheworld. TopicHighli
ght :
TheRegul at
oryFr amewor kofI
nnovat
iveTherapi
es
Mission:Through the schol arl
y pursuit
s oft eachi
ng, Biosi
mil
arDev elopment
research and ser
v i
ce,KBI PER is dedicated t
o create Nitr
osaminesAssessment
pharmacypr of
essionals commi tt
ed tol i
fel
ong l
earni
ng, Regulat
or yAspect s,Chall
engesandOpportunit
ies
fosteri
ng excell
ence and i nnovat
ions i n resear
ch, Regulat
or yPerspect iv
eonNut r
aceut
ical
s
developingandparti
cipatinginprofessi
onalpracti
ceand ThePhar maDigitalizati
on
communi t
yout
reach. Pharmacovi
gil
ance
ScanQRt
oRegi
ster
RecentupdateonANDA(
GDUF AI
I
I)
Est abli
shedi n1 995,KBI PERi sf i
rstsel f
-financephar macy Regulat
oryAspect
sonVacci
neandBi
ophar
maceut
ics
inst i
tute oft he st ate.Const i
tuentcol l
ege ofKSV,The
inst i
tuteoffersB.Phar m. ,M.Phar m. ,Phar m.D.,Phar m.D. I
ndi
anSoci
etyofPhar
maceut
icalRegul
ator
y
(PB) ,andPhDi nPhar maceut icalSciences. Insti
tuteof fer s Af
fai
rs(
ISPRA)
M. Phar m si
nce2003i nPhar macol ogy ,Phar macyPr act i
ce,
I
ndi
anSoci
etyofPhar
maceut
ical
Regul
ator
yAf
fai
rs(
ISPRA)i
s
Regul atoryAf fairs,Phar maceut i
csandQual it
yAssur ance.
a nati
onalbodyof Phar macyPr ofessi
onals.ISPRA is one
KBI PER ist he f irsti nstitutet o star tPhar mD cour se in
posi
tivethoughtwithpri
mar yobj
ect i
veto updat eregul
at or
y
Guj aratint heyearof201 0.Inst i
tut
ehasest ablishedt he
rel
atedinformati
onof cur r
entrules,regul
ationsandf uture
fir
st Dr ug I nfor mat ion Cent r
ei n Guj ar
at.Si nce t he
aspects.I
SPRAisforal
lstudents,
academi ci
ans,for
i
ncept i
on,i nst itut ei s not ably pr ogress i n academi c,
i
nterestedindi
vi
dualswit
hsuppor tfr
om Pharma
resear chandsoci aloutr each.Concomi tantaccr editati
on
andRegul
ator
yaut
hor
it
ies.
byt woaccr edit ationagenci es, NIRFrank ing,GSIRFr anking,
Cont
actUs
resear ch lab and I nstrument s,Ani malHouse,et hics
commi ttees,medi cinalgar den,museum,st r
ong al umni
witnessescr edi blegl ori
ousj ourneyofI nstit
uteyearaf ter conf
erence@kbi
per
.ac.
i
n 991
3343734,
9590548298
year .
K.
B.I
nst
itut
eofPhar
maceut
icalEducat
ion&Research(KBIPER)
,NrGH–6Crossroads,
Sect
or-
23,Gandhinagar
-382024,
Guj
arat
,Indi
a.